Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-560-437"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20121023.45.2-560-437"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"A majority of the European Parliament gave its consent to this trade agreement between the European Union and Israel on Conformity Assessment and Acceptance of Industrial Products (ACAA), which is part of the Association Agreement between the two parties. Presented as a purely technical agreement on the adoption of common standards for pharmaceutical products, this agreement allows for the mutual recognition of certificates of pharmaceutical products, thus reducing the time taken to bring products to market by shortening the approval procedures. Both parties’ pharmaceutical products will have easier access to the other party’s market. The ACAA will soon be followed by agreements in other sectors, such as toys, cosmetics, etc. I voted against this agreement, as it boosts relations between the EU and Israel without taking into account Israel’s policy with regard to the Palestinian Occupied Territories. Any deepening of relations between the EU and Israel, including in the economic and commercial spheres, must be dependent on Israel’s compliance with the United Nations resolutions on Palestine and respect for human rights. Therefore, by giving its consent to this agreement, the majority of the European Parliament is asserting its unconditional support for Israel’s policy in the Occupied Territories and is sending out more than a bad political signal."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples